Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-26-068495
Filing Date
2026-06-15
Accepted
2026-06-15 06:48:02
Documents
2
Period of Report
2026-06-15

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0294725-6k_scinai.htm 6-K 12427
2 PRESS RELEASE DATED JUNE 10, 2026 ea029472501ex99-1.htm EX-99.1 143857
  Complete submission text file 0001213900-26-068495.txt   157528
Mailing Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000
Business Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000 972-8-9302529
Scinai Immunotherapeutics Ltd. (Filer) CIK: 0001611747 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37353 | Film No.: 261089000
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)